Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

WuXi Biologics

Explore full profile

WuXi Biologics - Discovery, Development, Manufacturing - CDMO - CMO. Spun out of WuXi AppTec

Xuancheng, ChinaFounded 2000Biotech & Life Sciences
Valuation $17B Market cap · Aug/2026
Revenue $3.47B Latest reported FY
EBITDA $1.31B Latest reported FY

At a glance

Status
Listed
Founded
2000
Headquarters
Xuancheng, China
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom
News
News MiRABO Biotechnology raises $2.9M pre-Series A for its antibody drug AI Aug 20, 2026

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Dinghang Capital

Talent

Book a demo to see the people
Employees mapped 3,038 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 26 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
24 countries with
team presence
🇨🇳 China42.5%
🇮🇪 Ireland24.5%
🇺🇸 United States17.1%
🇩🇪 Germany8%
🇬🇧 United Kingdom4.1%
Top 5 of 24 shown
Web traffic by country
190K monthly visits
across markets
🇨🇳 China85.5%
🇺🇸 United States9.9%
🏳️ Korea1.7%
🏳️ Republic of1.5%
🇬🇧 United Kingdom1.1%
Top 5 markets shown

Patents

Estimated portfolio value
$95M

423 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where WuXi Biologics was the backer or acquirer, 2020–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across WuXi Biologics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        WuXi Biologics's portfolio, mapped.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about WuXi Biologics on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See WuXi Biologics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles